(NASDAQ: LNSR) Lensar's forecast annual revenue growth rate of 16.19% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.33%.
Lensar's revenue in 2026 is $60,264,000.On average, 4 Wall Street analysts forecast LNSR's revenue for 2026 to be $760,040,466, with the lowest LNSR revenue forecast at $718,796,818, and the highest LNSR revenue forecast at $794,649,748. On average, 4 Wall Street analysts forecast LNSR's revenue for 2027 to be $919,818,141, with the lowest LNSR revenue forecast at $769,365,438, and the highest LNSR revenue forecast at $1,069,423,119.
In 2028, LNSR is forecast to generate $1,332,156,342 in revenue, with the lowest revenue forecast at $1,279,818,557 and the highest revenue forecast at $1,371,348,251.